Quarterly report [Sections 13 or 15(d)]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Tables)

v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND SUPPLEMENTAL DISCLOSURES (Tables)
 6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
SCHEDULE OF CONTRACT LIABILITIES

The following table provides information about contract liabilities from contracts with customers, including significant changes in the contract liabilities balance during the period:

 

 

    June 30, 2025     December 31, 2024  
             
Beginning balance   $ 134     $ -  
                 
Increase due to deferral of revenue     3,330       167  
Decrease due to recognition of revenue     (3,286 )     (33 )
                 
Ending balance   $ 178     $ 134  
SCHEDULE OF CONCENTRATION RISK

 

    Six Months Ended June 30,
    2025   2024
The Company’s largest customers are presented below as a percentage of the aggregate        
         
Revenues   Two customers accounted for 11% and 15% of revenues   One customer that accounted for 52% of revenues
         
Accounts receivable   One customer that accounted for 31% of accounts receivable   No customers that accounted for greater than 10% of accounts receivable
         
The Company’s largest vendors are presented below as a percentage of the aggregate        
         
Purchases   No vendors accounted for greater than 10% of its purchases individually and in the aggregate   One vendor that accounted for 18% of its purchases individually and in the aggregate
SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION

Supplemental Cash Flow Information

 

 

      2025   2024  
    Six Months Ended June 30,  
    2025     2024  
             
Supplemental disclosures of cash flow information:                
Cash paid for interest   $ 1     $ 1  
Cash paid for income taxes   $ 3     $ 1  
                 
Supplemental disclosure of non-cash investing and financing activities:                
Settlement of accounts receivable with non-marketable equity securities   $ 563     $ -  
Issuance of common shares in connection with the purchase of Lyvecom     1,000       -  
Addition of contingent liability recorded in connection with the purchase of Lyvecom     600       -  
Fair value of common shares issued as payment on notes payable     -       2,777  
Fair value of common shares issued to redeem Series C preferred shares     -       656